| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $172.24M | $125.14M | $74.66M | $54.14M | $46.31M |
| R&D | $142.67M | $97.20M | $55.42M | $39.30M | $32.49M |
| SG&A | $29.57M | $27.94M | $19.24M | $14.84M | $13.82M |
| Operating Income | -$172.24M | -$125.14M | -$74.66M | -$54.14M | -$46.31M |
| Interest Expense | $2.00M | $748.00K | $0.00 | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$167.86M | -$115.86M | -$67.67M | -$52.98M | -$46.29M |
| EPS (basic) | -2.1000 | -2.3400 | -1.6500 | -1.8100 | -1.8000 |
| EPS (diluted) | -2.1000 | -2.3400 | -1.6500 | -1.8100 | -1.8000 |
| Shares (diluted) | – | – | – | – | – |